# TFAP2A

## Overview
TFAP2A is a gene that encodes the transcription factor AP-2 alpha, a protein crucial for regulating gene expression involved in development and differentiation across various human tissues. The protein, transcription factor AP-2 alpha, belongs to the Activator Protein-2 (TFAP2) family and plays a pivotal role in processes such as cell growth, differentiation, apoptosis, and tumorigenesis. It functions by binding to specific GC-rich DNA sequences within the regulatory regions of target genes, thereby modulating their transcription. This transcription factor is particularly significant in the context of melanocyte biology, influencing pigmentation and melanocyte differentiation, and is also involved in critical developmental pathways including the epithelial to mesenchymal transition (EMT). The broad functional spectrum of TFAP2A underscores its importance in maintaining cellular and developmental homeostasis (Orso2010Identification; Seberg2017Beyond; Dimitrova2017TFAP2A).

## Structure
The TFAP2A protein, encoded by the TFAP2A gene, is characterized by a structured domain architecture comprising a DNA-binding domain (DBD) and a helix-span-helix (HSH) domain. The DBD domain, spanning amino acids 202-273, includes two antiparallel beta-strands and three alpha-helices, which are crucial for DNA interaction. The HSH domain, covering amino acids 293-422, features a flat amphipathic alpha-helical fold made up of five alpha-helices (alpha4-alpha8). These domains are linked by a long loop that includes a 3_10-helix, essential for the structural integrity and function of the protein (Liu2023Structural).

TFAP2A functions as a dimer, and its dimerization is mediated through the HSH domain. The HSH domains of two TFAP2A molecules interact to form a homodimer, characterized by hydrophobic interactions with the alpha-helices positioned nearly perpendicular to each other. This arrangement creates a positively charged binding groove that is crucial for recognizing double-stranded DNA (Liu2023Structural).

Mutations in hydrophobic residues within the dimerization interface, such as V307, F379, V391, and L398, disrupt the stability of the dimer, leading to insoluble proteins. This highlights the importance of hydrophobic interactions in maintaining the structural stability of the TFAP2A dimer (Liu2023Structural).

## Function
TFAP2A, or transcription factor AP-2 alpha, plays a crucial role in the regulation of gene expression related to development and differentiation in various human cells. It is a member of the Activator Protein-2 (TFAP2) family, which influences the promoter activity of numerous genes critical for cell growth, differentiation, apoptosis, and tumorigenesis (Orso2010Identification). TFAP2A specifically binds to GC-rich DNA sequences within regulatory regions of target genes, mediating both activation and repression of gene transcription. This binding is essential for the normal function of several genes involved in pigmentation and melanocyte differentiation, such as MC1R, DCT, TYRP1, OCA2, and PMEL (Seberg2017Beyond).

In the context of melanocyte biology, TFAP2A is integral to the differentiation and function of these cells, regulating genes that are crucial for pigmentation processes. It operates alongside MITF, another key regulator in melanocyte development, to control the expression of pigmentation-related genes (Seberg2017TFAP2). The transcription factor also plays a role in the developmental choice between growth and differentiation in embryonic tissues, particularly the neural crest, which gives rise to melanocytes among other cell types (Hallberg2014Aberrant).

Moreover, TFAP2A's function extends to influencing epithelial plasticity and the epithelial to mesenchymal transition (EMT), which are critical in developmental and pathological processes (Dimitrova2017TFAP2A). This broad range of functions highlights the importance of TFAP2A in maintaining cellular and developmental homeostasis in humans.

## Clinical Significance
TFAP2A mutations and alterations in its expression are linked to several developmental disorders and cancers. One of the primary conditions associated with TFAP2A mutations is Branchio-Oculo-Facial Syndrome (BOFS), an autosomal dominant disorder characterized by distinctive facial features, skin anomalies, and hearing loss. Mutations in TFAP2A, particularly within its DNA-binding domain, lead to varied molecular properties of the proteins, affecting their ability to bind DNA and interact with other proteins, which contributes to the phenotypic variability seen in BOFS (Milunsky2008TFAP2A; Li2013Analysis).

In addition to BOFS, TFAP2A expression alterations play a significant role in cancer progression, particularly in melanoma. The gene is frequently silenced in metastatic melanoma through mechanisms such as aberrant CpG methylation of its promoter. This epigenetic modification correlates with decreased mRNA expression and is suggested as a key mechanism in the loss of TFAP2A expression during melanoma progression. Reactivating TFAP2A expression using epigenetic modifying drugs is considered a potential therapeutic strategy to slow melanoma progression (Hallberg2014Aberrant).

These findings underscore the importance of TFAP2A in both developmental disorders and cancer, highlighting its role in cellular differentiation and disease pathology.

## Interactions
TFAP2A, a transcription factor, engages in various physical interactions with proteins and nucleic acids, crucial for its role in gene regulation and cellular processes. It forms complexes with other transcription factors such as p53, enhancing p53's transcriptional activity on genes like p21, which is vital for cell cycle regulation (McPherson2002Tumor). Additionally, TFAP2A interacts with the CITED family of proteins, particularly CITED2 and CITED4, which influence its transcriptional activity. These interactions are mediated through specific domains within TFAP2A and are essential for its function as a co-activator in transcriptional regulation (BraganÃ§a2002Human; BraganÃ§a2003Physical).

TFAP2A also binds directly to DNA, recognizing specific palindromic GC-rich sequences, which allows it to regulate the expression of target genes such as CDKN1A independently of p53 (Scibetta2010Dual). The interaction with DNA is dynamic, adapting to cellular conditions to regulate gene expression effectively. Moreover, TFAP2A's interaction with the histone acetyltransferase p300 and its association with CITED2 facilitate its transcriptional activation capabilities, highlighting the importance of these interactions in modulating its function (BraganÃ§a2003Physical).


## References


[1. (Seberg2017TFAP2) Hannah E. Seberg, Eric Van Otterloo, Stacie K. Loftus, Huan Liu, Greg Bonde, Ramakrishna Sompallae, Derek E. Gildea, Juan F. Santana, J. Robert Manak, William J. Pavan, Trevor Williams, and Robert A. Cornell. Tfap2 paralogs regulate melanocyte differentiation in parallel with mitf. PLOS Genetics, 13(3):e1006636, March 2017. URL: http://dx.doi.org/10.1371/journal.pgen.1006636, doi:10.1371/journal.pgen.1006636. (75 citations) 10.1371/journal.pgen.1006636](https://doi.org/10.1371/journal.pgen.1006636)

[2. (Milunsky2008TFAP2A) Jeff M. Milunsky, Tom A. Maher, Geping Zhao, Amy E. Roberts, Heather J. Stalker, Roberto T. Zori, Michelle N. Burch, Michele Clemens, John B. Mulliken, Rosemarie Smith, and Angela E. Lin. Tfap2a mutations result in branchio-oculo-facial syndrome. The American Journal of Human Genetics, 82(5):1171â1177, May 2008. URL: http://dx.doi.org/10.1016/j.ajhg.2008.03.005, doi:10.1016/j.ajhg.2008.03.005. (167 citations) 10.1016/j.ajhg.2008.03.005](https://doi.org/10.1016/j.ajhg.2008.03.005)

[3. (Orso2010Identification) Francesca Orso, Davide CorÃ , Benedetta Ubezio, Paolo Provero, Michele Caselle, and Daniela Taverna. Identification of functional tfap2a and sp1 binding sites in new tfap2a-modulated genes. BMC Genomics, June 2010. URL: http://dx.doi.org/10.1186/1471-2164-11-355, doi:10.1186/1471-2164-11-355. (37 citations) 10.1186/1471-2164-11-355](https://doi.org/10.1186/1471-2164-11-355)

[4. (Hallberg2014Aberrant) Andrea R Hallberg, Sabine U Vorrink, Danielle R Hudachek, Kimberly Cramer-Morales, Mohammed M Milhem, Robert A Cornell, and Frederick E Domann. Aberrant cpg methylation of thetfap2agene constitutes a mechanism for loss oftfap2aexpression in human metastatic melanoma. Epigenetics, 9(12):1641â1647, December 2014. URL: http://dx.doi.org/10.4161/15592294.2014.988062, doi:10.4161/15592294.2014.988062. (39 citations) 10.4161/15592294.2014.988062](https://doi.org/10.4161/15592294.2014.988062)

[5. (BraganÃ§a2002Human) JosÃ© BraganÃ§a, Tracey Swingler, Fatima I.R. Marques, Tania Jones, Jyrki J. Eloranta, Helen C. Hurst, Toshihiro Shioda, and Shoumo Bhattacharya. Human creb-binding protein/p300-interacting transactivator with ed-rich tail (cited) 4, a new member of the cited family, functions as a co-activator for transcription factor ap-2. Journal of Biological Chemistry, 277(10):8559â8565, March 2002. URL: http://dx.doi.org/10.1074/jbc.m110850200, doi:10.1074/jbc.m110850200. (80 citations) 10.1074/jbc.m110850200](https://doi.org/10.1074/jbc.m110850200)

[6. (McPherson2002Tumor) Lisa A. McPherson, Alexander V. Loktev, and Ronald J. Weigel. Tumor suppressor activity of ap2Î± mediated through a direct interaction with p53. Journal of Biological Chemistry, 277(47):45028â45033, November 2002. URL: http://dx.doi.org/10.1074/jbc.m208924200, doi:10.1074/jbc.m208924200. (76 citations) 10.1074/jbc.m208924200](https://doi.org/10.1074/jbc.m208924200)

[7. (Seberg2017Beyond) Hannah E. Seberg, Eric Van Otterloo, and Robert A. Cornell. Beyond <scp>mitf</scp>: multiple transcription factors directly regulate the cellular phenotype in melanocytes and melanoma. Pigment Cell &amp; Melanoma Research, 30(5):454â466, August 2017. URL: http://dx.doi.org/10.1111/pcmr.12611, doi:10.1111/pcmr.12611. (101 citations) 10.1111/pcmr.12611](https://doi.org/10.1111/pcmr.12611)

[8. (Scibetta2010Dual) Angelo G. Scibetta, Ping-Pui Wong, KaYi V. Chan, Monica Canosa, and Helen C. Hurst. Dual association by tfap2a during activation of the p21cip/cdkn1a promoter. Cell Cycle, 9(22):4525â4532, November 2010. URL: http://dx.doi.org/10.4161/cc.9.22.13746, doi:10.4161/cc.9.22.13746. (21 citations) 10.4161/cc.9.22.13746](https://doi.org/10.4161/cc.9.22.13746)

[9. (Liu2023Structural) Ke Liu, Yuqing Xiao, Linyao Gan, Weifang Li, Jin Zhang, and Jinrong Min. Structural basis for specific dna sequence motif recognition by the tfap2 transcription factors. Nucleic Acids Research, 51(15):8270â8282, July 2023. URL: http://dx.doi.org/10.1093/nar/gkad583, doi:10.1093/nar/gkad583. (3 citations) 10.1093/nar/gkad583](https://doi.org/10.1093/nar/gkad583)

[10. (Li2013Analysis) Hong Li, Ryan Sheridan, and Trevor Williams. Analysis of tfap2a mutations in branchio-oculo-facial syndrome indicates functional complexity within the ap-2Î± dna-binding domain. Human Molecular Genetics, 22(16):3195â3206, April 2013. URL: http://dx.doi.org/10.1093/hmg/ddt173, doi:10.1093/hmg/ddt173. (42 citations) 10.1093/hmg/ddt173](https://doi.org/10.1093/hmg/ddt173)

[11. (BraganÃ§a2003Physical) JosÃ© BraganÃ§a, Jyrki J. Eloranta, Simon D. Bamforth, J. Claire Ibbitt, Helen C. Hurst, and Shoumo Bhattacharya. Physical and functional interactions among ap-2 transcription factors, p300/creb-binding protein, and cited2. Journal of Biological Chemistry, 278(18):16021â16029, May 2003. URL: http://dx.doi.org/10.1074/jbc.m208144200, doi:10.1074/jbc.m208144200. (193 citations) 10.1074/jbc.m208144200](https://doi.org/10.1074/jbc.m208144200)

[12. (Dimitrova2017TFAP2A) Yoana Dimitrova, Andreas J. Gruber, Nitish Mittal, Souvik Ghosh, Beatrice Dimitriades, Daniel Mathow, William Aaron Grandy, Gerhard Christofori, and Mihaela Zavolan. Tfap2a is a component of the zeb1/2 network that regulates tgfb1-induced epithelial to mesenchymal transition. Biology Direct, April 2017. URL: http://dx.doi.org/10.1186/s13062-017-0180-7, doi:10.1186/s13062-017-0180-7. (30 citations) 10.1186/s13062-017-0180-7](https://doi.org/10.1186/s13062-017-0180-7)